Specific humoral immunity after immunization with vaccine contained Leningrad-3 (L-3) mumps virus strain of different potency

by E. V. Оtmshevskaya, M. V. Kulak, E. K. Bukin, G. M. Ignatev
Published 2019-08-01

Molecular-genetic study of the RA-27/3 strain used for production of rubella vaccine

by G. M. Ignatev, E. V. Atrashevskaya, L. L. Suchanova, E. S. Sidorenko, N. A. Netesova
Published 2019-09-01

Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years

by I. V. Fel'dblyum, S. D. Novgorodova, G. M. Ignat'ev, S. O. Golodnova, V. P. Trukhin, S. Ya Melnikov
Published 2018-02-01

The Study in Animal Models of Local Action, Acute and Chronic Toxicity of Inactivated Influenza Vaccine Ultriks in Syringe

by O. G. Kurskaya, K. A. Sharshov, A. Yu. Alekseev, M. A. Gulyaeva, A. M. Shestopalov, L. V. Shestopalova, G. M. Ignatev, V. A. Shkurupiy
Published 2015-06-01

REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF DOMESTIC FLU-M INACTIVATED SPLIT INFLUENZA VACCINE FOR THE IMMUNIZATION OF ADULTS AGED BETWEEN 18 AND 60

by I. V. Feldblyum, K. A. Subbotina, S. D. Novgorodova, G. M. Ignatev, M. Kh. Alyeva, M. K. Erofeeva, V. G. Orlovsky, I. A. Leneva, S. Ya. Melnikov, E. V. Kazakova, E. P. Nacharova, V. P. Trukhin
Published 2018-10-01